Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.74 |
| ▸ | ALPI | P09923 | 1/20 | 0.74 |
| ▸ | PKM | P14618 | 1/20 | 0.74 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.74 |
| ▸ | XIAP | P98170 | 1/20 | 0.74 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.58 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.53 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | CPA1 | P15085 | 2/20 | 0.48 |
| ▸ | CPA3 | P15088 | 2/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dl-Phenylalanine SCHEMBL3439692 | 0.88 | SLC7A5 (0.74) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL2939606 | 0.88 | SLC7A5 (0.74) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL1331777 | 0.85 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL2785094 | 0.85 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL1331205 | 0.85 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL23159186 | 0.85 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL1449128 | 0.85 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Phenylalanine SCHEMBL8835931 | 0.85 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL288606 | 0.85 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP | |
| Dl-Phenylalanine SCHEMBL1331829 | 0.85 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250102526-A1 | SYSTEMS, METHODS, AND BIOMARKERS FOR DETERMINING THE METABOLIC STATE OF RED BLOOD CELLS AND PLATELETS | B64 CONSULTING EHF (IS) | 2025-03-27 | — | — | US | disclosed |
| US-12196766-B2 | Systems, methods, and biomarkers for determining the metabolic state of red blood cells and platelets | B64 CONSULTING EHF (IS) | 2025-01-14 | — | — | US | disclosed |
| EP-4339295-A2 | STORAGE DEVICE, SYSTEM AND METHOD FOR DETERMINING THE METABOLIC STATE OF RED BLOOD CELLS AND PLATELETS | B64 CONSULTING EHF (IS) | 2024-03-20 | — | — | EP | disclosed |
| EP-3146336-B1 | STORAGE DEVICE, SYSTEM AND METHOD FOR DETERMINING THE METABOLIC STATE OF RED BLOOD CELLS AND PLATELETS | B64 CONSULTING EHF (IS) | 2024-02-07 | — | — | EP | disclosed |
| CN-117025643-A | Application of soybean GmCGS2 gene in improving soybean protein and methionine | 吉林大学 | 2023-11-10 | — | — | CN | disclosed |
| US-20200400692-A1 | SYSTEMS, METHODS, AND BIOMARKERS FOR DETERMINING THE METABOLIC STATE OF RED BLOOD CELLS AND PLATELETS | B64 CONSULTING EHF (IS) | 2020-12-24 | — | — | US | disclosed |
| US-10557861-B2 | Systems, methods, and biomarkers for determining the metabolic state of red blood cells and platelets | UNIVERSITY OF ICELAND, CENTER FOR SYSTEMS BIOLOGY (IS) | 2020-02-11 | — | — | US | disclosed |
| US-20170160293-A1 | SYSTEMS, METHODS, AND BIOMARKERS FOR DETERMINING THE METABOLIC STATE OF RED BLOOD CELLS AND PLATELETS | B64 CONSULTING EHF (IS) | 2017-06-08 | — | — | US | disclosed |
| EP-3146336-A1 | SYSTEMS, METHODS, AND BIOMARKERS FOR DETERMINING THE METABOLIC STATE OF RED BLOOD CELLS AND PLATELETS | University of Iceland, Center for Systems Biology (IS) | 2017-03-29 | — | — | EP | disclosed |
| WO-2015179251-A1 | SYSTEMS, METHODS, AND BIOMARKERS FOR DETERMINING THE METABOLIC STATE OF RED BLOOD CELLS AND PLATELETS | UNIVERSITY OF ICELAND, CENTER FOR SYSTEMS BIOLOGY (IS) | 2015-11-26 | — | — | WO | disclosed |
| WO-2011017395-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2011-02-10 | — | — | WO | disclosed |
| US-20100222396-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2010-09-02 | — | — | US | disclosed |
| WO-2010086366-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2010-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222396-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | CYP11B2, CYP11B1, BBC3 | SLC7A5 2785/4885ALPI 359/4885PKM 3853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.